Milestone Asset Management LLC Has $1.23 Million Stake in Cencora, Inc. (NYSE:COR)

Milestone Asset Management LLC raised its holdings in shares of Cencora, Inc. (NYSE:COR - Free Report) by 430.2% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 5,461 shares of the company's stock after purchasing an additional 4,431 shares during the period. Milestone Asset Management LLC's holdings in Cencora were worth $1,227,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds also recently modified their holdings of the company. Concord Wealth Partners bought a new position in Cencora during the 3rd quarter worth approximately $30,000. Householder Group Estate & Retirement Specialist LLC boosted its position in shares of Cencora by 85.2% during the fourth quarter. Householder Group Estate & Retirement Specialist LLC now owns 150 shares of the company's stock worth $33,000 after purchasing an additional 69 shares in the last quarter. Ashton Thomas Securities LLC acquired a new position in shares of Cencora in the 3rd quarter valued at $41,000. Modus Advisors LLC bought a new stake in shares of Cencora in the 4th quarter valued at $54,000. Finally, Carolina Wealth Advisors LLC lifted its holdings in Cencora by 366.7% during the third quarter. Carolina Wealth Advisors LLC now owns 266 shares of the company's stock worth $60,000 after acquiring an additional 209 shares in the last quarter. Institutional investors own 97.52% of the company's stock.

Insider Buying and Selling

In other Cencora news, Chairman Steven H. Collis sold 50,000 shares of the company's stock in a transaction on Monday, November 25th. The stock was sold at an average price of $243.97, for a total value of $12,198,500.00. Following the transaction, the chairman now directly owns 326,557 shares of the company's stock, valued at $79,670,111.29. This represents a 13.28 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Also, EVP Silvana Battaglia sold 1,678 shares of Cencora stock in a transaction on Friday, December 20th. The stock was sold at an average price of $228.72, for a total value of $383,792.16. Following the sale, the executive vice president now directly owns 20,329 shares of the company's stock, valued at $4,649,648.88. This represents a 7.62 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 73,187 shares of company stock valued at $17,790,912. 15.80% of the stock is owned by insiders.

Analyst Ratings Changes

A number of equities research analysts have recently commented on COR shares. Mizuho began coverage on Cencora in a research report on Wednesday, December 4th. They set an "outperform" rating and a $280.00 price target on the stock. Barclays lifted their target price on Cencora from $263.00 to $290.00 and gave the company an "overweight" rating in a research report on Thursday, November 7th. Robert W. Baird upped their price target on Cencora from $287.00 to $292.00 and gave the stock an "outperform" rating in a research report on Thursday, November 7th. Leerink Partners lowered their price objective on shares of Cencora from $277.00 to $275.00 and set an "outperform" rating on the stock in a report on Monday, October 7th. Finally, Evercore ISI increased their target price on shares of Cencora from $250.00 to $285.00 and gave the stock an "outperform" rating in a report on Thursday, November 7th. Two investment analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company. According to MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $278.40.

Cencora Stock Performance

NYSE:COR traded up $2.95 during mid-day trading on Thursday, hitting $258.89. The stock had a trading volume of 514,596 shares, compared to its average volume of 1,222,096. Cencora, Inc. has a twelve month low of $214.77 and a twelve month high of $261.25. The company has a debt-to-equity ratio of 4.84, a quick ratio of 0.53 and a current ratio of 0.88. The stock has a market cap of $50.04 billion, a price-to-earnings ratio of 34.50, a PEG ratio of 1.54 and a beta of 0.49. The company's 50 day simple moving average is $238.30 and its 200 day simple moving average is $235.44.

Cencora Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, November 29th. Stockholders of record on Friday, November 15th were paid a dividend of $0.55 per share. This is an increase from Cencora's previous quarterly dividend of $0.51. This represents a $2.20 annualized dividend and a dividend yield of 0.85%. The ex-dividend date was Friday, November 15th. Cencora's payout ratio is currently 29.29%.

About Cencora

Cencora, Inc sources and distributes pharmaceutical products. The company's U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to various institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; and sales force services to manufacturers.